Advertisement

Latest News

Immunomodulation for Plant-Based Food Allergy, With María José Torres Jaén, MD, PhD

1 hour ago

At AAAAI 2026, Torres highlighted phase 3 peach immunotherapy research, nanostructure preclinical models, and a phase 2 prebiotic trial for LTP allergy.

What Is the Significance of New Data on Imsidolimab for GPP? With Neal Bhatia, MD

3 hours ago

This interview highlights the significance of the potential FDA approval of imsidolimab for patients with generalized pustular psoriasis (GPP).

Multidisciplinary Care and Addressing Pill Burden in HF, With Bernard Kadosh, MD, and Eiran Gorodeski, MD, MPH

4 hours ago

Kadosh and Gorodeski discuss the value of including non-specialists in HF care and the challenges of prescribing 4 pills in a time of increasing medical distrust.

BW-20805 Reduces HAE Attacks in Phase 2 Trial, With Markus Magerl, MD

6 hours ago

At AAAAI 2026, Magerl discusses phase 2 data showing BW-20805 reduced hereditary angioedema attacks by up to 100% with dosing intervals of up to 6 months.

AMI Mortality Increasing Among Young Adults With Nontraditional Risk Factors, With Mohan Satish, MD

6 hours ago

Satish discusses his recent study highlighting significant increases in first AMI in-hospital mortality among young adults, particularly in women.

Advertisement
Advertisement